Clinical Trials Directory

Trials / Completed

CompletedNCT05186662

Comparing the Efficacy of WeChat-based Patient Education and Conventional Patient Education in the Management of Helicobacter Pylori Eradication

Status
Completed
Phase
Study type
Observational
Enrollment
1,017 (actual)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

we conducted a retrospective study to compare the efficacy of WeChat-based patient education and conventional patient education in the management of Helicobacter pylori eradication.

Detailed description

This is a single-institute retrospective study comparing the efficacy of WeChat-based patient education and conventional patient education in the management of Helicobacter pylori eradication. We identified all patients aged between 18-75 years old and had been prescribed a 14-day course of bismuth-contained quadruple therapy for H. pylori infection in our outpatient clinics between 1 July 2019 and 31 July 2021. H. pylori infection was confirmed by any two positive outcomes of rapid urease test,13C-urea breath test (UBT) and histopathology. Patients who had H. pylori therapy history, using other therapeutic regimens or unwilling to take prescribed medications were excluded. Demographic data, treatment regimens, outcomes of therapy, adherence to therapy and adverse event were retrieved. The main indicator is eradication rate, as the secondary indicators are compliance and adverse events.

Conditions

Interventions

TypeNameDescription
OTHERpatient educationpatients in experimental group were asked to join a WeChat group, which was governed by experienced gastroenterologists. Relevant knowledge of H. pylori eradication was released in the group chat irregularly. Patients in WeChat group were allowed to ask questions at any time during the whole treatment process, soon afterwards, suggestions were given.
OTHERpatient educationPatients in the control group received verbal education and a specifically designed printout with detailed instructions.

Timeline

Start date
2019-07-01
Primary completion
2021-07-31
Completion
2021-12-07
First posted
2022-01-11
Last updated
2022-03-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05186662. Inclusion in this directory is not an endorsement.